Main Session: New Drugs and Novel Mechanisms of Action in Treating Patients with Multiple Myeloma

What are the mechanisms of action of the new and emerging agents for multiple myeloma?

Jonathan Kaufman, MD
The Winship Cancer Institute of Emory University

Copyright © 2010-2018 Harborside Press, LLC All rights reserved.               
Home | Current Issue | Previous Issue | Submissions | About JADPRO | Advertising | Privacy Policy | Contact | Copyright Notice/Disclaimer | Subscribe
Bot trap - Don't go here